Shanghai Bio-heart Biological Technology Co., Ltd. (2185.HK)
HKD 1.66
(3.75%)
HKD 1.66
(3.75%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -49.75 Million | -158.85 Million | -105.45 Million | -54.27 Million | -24.21 Million |
| Net Income | -194.36 Million | -237.5 Million | -435.62 Million | -365.78 Million | -26.89 Million |
| Depreciation & Amortization | 23.59 Million | 24.25 Million | 15.94 Million | 9.71 Million | 8.73 Million |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | 47.62 Million | 140.48 Million | 318.72 Million | 268.11 Million | - |
| Change in working capital | 50.5 Million | -56.42 Million | -20.4 Million | -1.05 Million | -6.13 Million |
| Other non-cash items | 122.09 Million | 159.33 Million | 366.52 Million | 322.27 Million | 14.51 Million |
| Investing Cash Flow | -36.3 Million | -121.74 Million | -41.82 Million | -253.21 Million | -6.42 Million |
| Investments in PPE | -19.85 Million | -34.93 Million | -41.82 Million | -6.45 Million | -16.99 Million |
| Acquisitions | 125.96 Thousand | -24.65 Million | - | -247.68 Million | - |
| Investment purchases | -16.57 Million | -86.81 Million | - | -593.31 Thousand | -5.8 Million |
| Sales/Maturities of investments | - | - | - | 1.51 Million | 16.37 Million |
| Other Investing Activities | 3.85 Million | - | - | - | - |
| Financing Cash Flow | -6.42 Million | -40.9 Million | 462.41 Million | 812.42 Million | 48.86 Million |
| Debt repayment | - | - | - | -6 Million | -5.25 Million |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | - | -34.23 Million | 395.24 Million | 824.1 Million | 44.42 Million |
| Other Financing Activities | -619.9 Thousand | -2.49 Million | 467.58 Million | -4.36 Million | 39.17 Million |
| Accounts receivables | - | - | - | - | 3.03 Million |
| Accounts payables | - | -11.62 Thousand | - | - | - |
| Inventory | -4.39 Million | - | - | - | - |
| Other working capital | 54.9 Million | -56.41 Million | -20.4 Million | -1.05 Million | -9.16 Million |
| Cash at beginning of period | 506.71 Million | 866.72 Million | 537.88 Million | 23.12 Million | 4.9 Million |
| Cash at end of period | 406.75 Million | 506.71 Million | 866.72 Million | 537.88 Million | 23.12 Million |
| Capital Expenditure | -19.85 Million | -34.93 Million | -41.82 Million | -6.45 Million | -16.99 Million |
| Effect of forex changes on cash | 1.82 Million | 19.26 Million | -6.61 Million | -16.35 Million | - |
| Net cash flow / Change in cash | -99.95 Million | -360 Million | 328.83 Million | 514.76 Million | 18.22 Million |
| Free Cash Flow | -69.61 Million | -193.78 Million | -147.28 Million | -60.73 Million | -41.2 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -13.87 Thousand | -13.99 Thousand | -49.34 Thousand | -194.36 Million | -48.1 Thousand | -46.53 Thousand |
| Depreciation & Amortization | 2156.58 | 2175.16 | 4896.15 | 23.59 Million | 4773.42 | 6725.04 |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | 8060.14 | 47.62 Million | 7858.09 | 17.8 Thousand |
| Change in working capital | -27.88 Thousand | -28.12 Thousand | 16.93 Thousand | 50.5 Million | 16.5 Thousand | 8553.45 |
| Other non-cash items | -1718.71 | -1733.52 | 13.44 Thousand | 122.09 Million | 13.1 Thousand | -7120.86 |
| Investing Cash Flow | -10.29 Thousand | -10.38 Thousand | -2744.84 | -36.3 Million | -2676.03 | -12.88 Thousand |
| Investments in PPE | -10.65 Thousand | -10.74 Thousand | -4106.80 | -19.85 Million | -4003.86 | -5534.36 |
| Acquisitions | - | - | 123.15 Thousand | 125.96 Thousand | - | - |
| Investment purchases | - | - | 759.24 Thousand | -16.57 Million | - | -16.96 Million |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 362.12 | 365.24 | 1361.97 | - | 1327.83 | -7353.05 |
| Financing Cash Flow | -599.05 | -604.21 | -1178.79 | -6.42 Million | -1149.25 | -1985.01 |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 634.46 Thousand | - | - | -634.46 Thousand |
| Other Financing Activities | -599.05 | -604.21 | -1178.79 | -619.9 Thousand | -1149.25 | -1985.01 |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | 340.63 | 343.56 | -2189.27 | -4.39 Million | -2134.39 | - |
| Other working capital | -28.22 Thousand | -28.47 Thousand | 19.12 Thousand | 54.9 Million | 18.64 Thousand | 8553.45 |
| Cash at beginning of period | - | - | 420.02 Million | 506.71 Million | - | 506.71 Million |
| Cash at end of period | -51.86 Thousand | -52.31 Thousand | 406.75 Million | 406.75 Million | -10.66 Thousand | 420.02 Million |
| Capital Expenditure | -10.65 Thousand | -10.74 Thousand | -4106.80 | -19.85 Million | -4003.86 | -5534.36 |
| Effect of forex changes on cash | 356.74 | 359.82 | -1012.12 | 1.82 Million | -986.75 | 1977.99 |
| Net cash flow / Change in cash | -51.86 Thousand | -52.31 Thousand | -13.26 Million | -99.95 Million | -10.66 Thousand | -86.69 Million |
| Free Cash Flow | -51.98 Thousand | -52.43 Thousand | -10.11 Thousand | -69.61 Million | -9861.63 | -26.11 Thousand |
600483
002383
KTTA
0737
6147
PIKK